We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
151
Bio-Techne
TECH
$11.2B
$922K 0.01%
11,531
-1,995
-15% -$150K
DBRG icon
152
DigitalBridge
DBRG
$2.93B
$916K 0.01%
+64,839
New +$860K
TRDA icon
153
Entrada Therapeutics
TRDA
$236M
$916K 0.01%
+57,331
New +$903K
CMAX
154
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$901K 0.01%
530,232
– –
MU icon
155
Micron Technology
MU
$1.02T
$895K 0.01%
8,627
+1,834
+27% +$192K
CFG icon
156
Citizens Financial Group
CFG
$30.1B
$890K 0.01%
21,678
-3,201
-13% -$129K
SMPL icon
157
Simply Good Foods
SMPL
$943M
$886K 0.01%
25,494
+5,828
+30% +$197K
MRCY icon
158
Mercury Systems
MRCY
$6.23B
$882K 0.01%
23,851
+13,282
+126% +$467K
VLTO icon
159
Veralto
VLTO
$23.2B
$874K 0.01%
+7,814
New +$826K
MAX icon
160
MediaAlpha
MAX
$734M
$871K 0.01%
48,093
+20,463
+74% +$326K
SWK icon
161
Stanley Black & Decker
SWK
$14.6B
$868K 0.01%
+7,879
New +$756K
CAH icon
162
Cardinal Health
CAH
$53.7B
$867K 0.01%
+7,849
New +$821K
USPH icon
163
US Physical Therapy
USPH
$1.17B
$864K 0.01%
+10,214
New +$906K
SYNA icon
164
Synaptics
SYNA
$4.55B
$861K 0.01%
+11,099
New +$890K
NBBK icon
165
NB Bancorp
NBBK
$983M
$861K 0.01%
+46,371
New +$820K
WRB icon
166
W.R. Berkley
WRB
$28.1B
$860K 0.01%
+15,155
New +$851K
KBR icon
167
KBR
KBR
$4.67B
$858K 0.01%
+13,173
New +$857K
DG icon
168
Dollar General
DG
$27.2B
$857K 0.01%
10,132
+2,931
+41% +$321K
ESAB icon
169
ESAB
ESAB
$5.49B
$856K 0.01%
+8,056
New +$797K
DE icon
170
Deere & Co
DE
$169B
$856K 0.01%
2,051
+462
+29% +$174K
NVRI icon
171
Enviri
NVRI
$620M
$852K 0.01%
+82,364
New +$867K
SKYT icon
172
SkyWater Technology
SKYT
$1.55B
$848K 0.01%
+93,357
New +$778K
COST icon
173
Costco
COST
$422B
$838K 0.01%
+945
New +$820K
WDFC icon
174
WD-40
WDFC
$3.13B
$834K 0.01%
+3,233
New +$811K
HTLD icon
175
Heartland Express
HTLD
$1.06B
$833K 0.01%
+67,828
New +$832K
5 6
7
8 9

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.